The Morning Filter cover image

4 Stocks to Buy for the Long-Term While They’re Still Undervalued

The Morning Filter

00:00

Bristol Myers Offers Yield Despite Patent Losses

Dave Sekera says Bristol Myers is undervalued because investors fear patent expirations, while its pipeline, low valuation, and sustainable dividend support long-term recovery.

Play episode from 33:38
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app